We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$585B
AUM Growth
+$29.3B
Cap. Flow
+$1.02B
Cap. Flow %
0.17%
Top 10 Hldgs %
17.95%
Holding
2,642
New
88
Increased
1,025
Reduced
900
Closed
73

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$2.03B
2
DD icon
DuPont de Nemours
DD
+$1.83B
3
CCI icon
Crown Castle
CCI
+$1.58B
4
MSFT icon
Microsoft
MSFT
+$1.48B
5
TRU icon
TransUnion
TRU
+$781M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.53%
3 Technology 15%
4 Consumer Discretionary 13.37%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBNK
726
DELISTED
United Financial Bancorp, Inc.
UBNK
$73M 0.01%
3,989,781
-128,850
-3% -$2.24M
KYNB
727
Kyntra Bio
KYNB
$28.5M
$72.8M 0.01%
54,120
+21,902
+68% +$23.1M
ETFC
728
DELISTED
E*Trade Financial Corporation
ETFC
$72.7M 0.01%
1,668,156
-169,789
-9% -$6.9M
LDL
729
DELISTED
Lydall, Inc.
LDL
$72.4M 0.01%
1,262,789
+53,708
+4% +$2.68M
TAP icon
730
Molson Coors Class B
TAP
$7.85B
$71.9M 0.01%
880,629
-16,146
-2% -$1.42M
PRAA icon
731
PRA Group
PRAA
$762M
$71.6M 0.01%
2,498,270
+2,045,822
+452% +$68.3M
ELME
732
Elme Communities
ELME
$144M
$71.4M 0.01%
2,179,938
+176,502
+9% +$5.75M
PSX icon
733
Phillips 66
PSX
$92.8B
$71.3M 0.01%
778,017
-41,647
-5% -$3.53M
CLR
734
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$70.7M 0.01%
1,831,357
-165,585
-8% -$5.62M
BSX icon
735
Boston Scientific
BSX
$74.9B
$70.2M 0.01%
2,407,443
-98,245
-4% -$2.71M
HEI.A icon
736
HEICO Corp Class A
HEI.A
$38.1B
$69.4M 0.01%
1,778,672
+178,895
+11% +$6.55M
OII icon
737
Oceaneering
OII
$5.11B
$69.3M 0.01%
2,637,206
+764,202
+41% +$18.5M
BERY
738
DELISTED
Berry Global Group, Inc.
BERY
$68.8M 0.01%
1,322,692
+120,894
+10% +$6.32M
EBAY icon
739
eBay
EBAY
$46.5B
$68.7M 0.01%
1,785,889
-90,615
-5% -$3.29M
LTRPA
740
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$68.3M 0.01%
5,530,002
-18,160
-0.3% -$226K
MOS icon
741
The Mosaic Company
MOS
$6.92B
$67.5M 0.01%
3,124,442
+112,667
+4% +$2.44M
NSC icon
742
Norfolk Southern
NSC
$75.9B
$67.3M 0.01%
508,626
-22,321
-4% -$2.71M
PCRX icon
743
Pacira BioSciences
PCRX
$924M
$67.2M 0.01%
1,790,052
-266,740
-13% -$10.7M
ESRX
744
DELISTED
Express Scripts Holding Company
ESRX
$67.1M 0.01%
1,060,437
-91,877
-8% -$5.71M
MCO icon
745
Moody's
MCO
$84.6B
$67M 0.01%
481,377
-22,340
-4% -$2.94M
ZNGA
746
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$66.8M 0.01%
17,662,481
+1,310,711
+8% +$4.83M
ACBI
747
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$66.7M 0.01%
3,673,516
+497,447
+16% +$9.07M
ZEN
748
DELISTED
ZENDESK INC
ZEN
$66.3M 0.01%
2,279,023
-1,138,348
-33% -$32M
AEGN
749
DELISTED
Aegion Corp
AEGN
$65.5M 0.01%
2,813,590
-13,200
-0.5% -$291K
DO
750
DELISTED
Diamond Offshore Drilling
DO
$65.2M 0.01%
4,495,884
+507,380
+13% +$6.11M

Similar funds

T. Rowe Price Associates's Q3 2017 Portfolio in Review

As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
  • T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
  • T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
  • T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
  • T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.

Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.